Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiyang Yu

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.
Nature Communications|February 10, 2023
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instabilityZaili Luo, Dazhuan Xin, Yunfei Liao, et al.
Molecular Cancer Therapeutics|August 20, 2021
SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging AgentsJessica Gartrell, Marcia Mellado-Largarde, Michael R Clay, et al.
Scientific Reports|March 5, 2021
Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL)Timothy I Shaw, Li Dong, Liqing Tian, et al.
Nature Cancer|December 30, 2022
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancerTizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
Somatic mitochondrial DNA mutations are a source of heterogeneity among primary leukemic cellsKelly McCastlain, Catherine Welsh, Yonghui Ni, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALLYuxuan Liu, Haowen Jiang, Jingjing Liu, et al.
Science Advances|September 10, 2025
Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cellsKelly McCastlain, Catherine Welsh, Yonghui Ni, et al.
Cancer Cell|December 3, 2013
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaErich Piovan, Jiyang Yu, Valeria Tosello, et al.
Science (New York, N.Y.)|October 10, 2024
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapyTae Gun Kang, Xin Lan, Tian Mi, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Blood|May 28, 2025
Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicinCarolin S Escherich, Zhenhua Li, Kelly R Barnett, et al.
Nature Communications|February 10, 2023
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instabilityZaili Luo, Dazhuan Xin, Yunfei Liao, et al.
Molecular Cancer Therapeutics|August 20, 2021
SLFN11 is Widely Expressed in Pediatric Sarcoma and Induces Variable Sensitization to Replicative Stress Caused By DNA-Damaging AgentsJessica Gartrell, Marcia Mellado-Largarde, Michael R Clay, et al.
Scientific Reports|March 5, 2021
Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL)Timothy I Shaw, Li Dong, Liqing Tian, et al.
Nature Cancer|December 30, 2022
Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancerTizita Z Zeleke, Qingfei Pan, Codruta Chiuzan, et al.
Medrxiv : the Preprint Server for Health Sciences|October 14, 2024
Somatic mitochondrial DNA mutations are a source of heterogeneity among primary leukemic cellsKelly McCastlain, Catherine Welsh, Yonghui Ni, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Uridine Metabolism as a Targetable Metabolic Achilles' Heel for chemo-resistant B-ALLYuxuan Liu, Haowen Jiang, Jingjing Liu, et al.
Science Advances|September 10, 2025
Somatic mtDNA mutations at intermediate levels of heteroplasmy are a source of functional heterogeneity among primary leukemic cellsKelly McCastlain, Catherine Welsh, Yonghui Ni, et al.
Cancer Cell|December 3, 2013
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemiaErich Piovan, Jiyang Yu, Valeria Tosello, et al.
Science (New York, N.Y.)|October 10, 2024
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapyTae Gun Kang, Xin Lan, Tian Mi, et al.
Pageof 11